000 01436 a2200373 4500
005 20250516152855.0
264 0 _c20131022
008 201310s 0 0 eng d
022 _a2476-762X
024 7 _a10.7314/apjcp.2013.14.4.2413
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlimujiang, S
245 0 0 _aEpidermal growth factor receptor tyrosine kinase inhibitor versus placebo as maintenance therapy for advanced non- small-cell lung cancer: a meta-analysis of randomized controlled trials.
_h[electronic resource]
260 _bAsian Pacific journal of cancer prevention : APJCP
_c2013
300 _a2413-9 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aPrognosis
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aZhang, Tao
700 1 _aHan, Zhi-Gang
700 1 _aYuan, Shuai-Fei
700 1 _aWang, Qiang
700 1 _aYu, Ting-Ting
700 1 _aShan, Li
773 0 _tAsian Pacific journal of cancer prevention : APJCP
_gvol. 14
_gno. 4
_gp. 2413-9
856 4 0 _uhttps://doi.org/10.7314/apjcp.2013.14.4.2413
_zAvailable from publisher's website
999 _c22797066
_d22797066